Labshake search
Citations for BioLegend :
701 - 750 of 4666 citations for Recombinant Mouse CD19 Antigen His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... washed with FACS buffer (PBS supplemented with 1 mM EDTA and 2% fetal calf serum) and stained with a live/dead marker (viability-eF780, eBiosciences) together with CD19-AF700 (HIB19, BioLegend), CD20-PE-CF594 (2H7 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Antibodies used to distinguish the different cell populations included Brilliant violet 421 anti-human CD19 (Biolegend, San Diego, CA, USA), PE anti-human CD45 (Biolegend) ...
-
bioRxiv - Bioengineering 2023Quote: ... for 5 min on ice and then stained with fluorochrome conjugated antibodies: CD19 (PerCP-Cy5.5, clone: 1D3, BioLegend, cat: 152406) CD95 (PE-Cy7 ...
-
bioRxiv - Immunology 2024Quote: ... cells were harvested and stained with viability dyes and surface antibodies (anti-CD19, anti-CD11b, anti-CD3, and anti-CD4, BioLegend) for 30 minutes at 4°C followed by fixation with 2% paraformaldehyde ...
-
bioRxiv - Neuroscience 2021Quote: ... then incubated with oligonucleotide-tagged anti-VCAM1 and anti-CD24 antibodies (BioLegend, Supplementary Table 5) on ice for 30 minutes ...
-
bioRxiv - Cell Biology 2023Quote: ... as well as 0.5 ug each of the 10 TotalSeq-B oligo-tagged antibodies (BioLegend) listed in Supplementary Table 3 were added and cell pellets were suspended ...
-
bioRxiv - Cell Biology 2021Quote: ... Mac-1-PE-Cy7 and FcγR-PE (eBioscience, 12-0161-83) for myeloid differentiation, or Mac-1-APC (eBioscience, 17-0112-82) and CD19-PB (BioLegend, 115523) for lymphoid differentiation on OP9 cells ...
-
bioRxiv - Immunology 2021Quote: 600 million cells from human tonsils were resuspended in Miltenyi magnetic-activated cell sorting (MACS) buffer and stained with biotinylated anti-human CD19 (clone: HIB19; BioLegend, #555411) on ice for 30 min ...
-
bioRxiv - Microbiology 2023Quote: ... The following antibodies were used for flow cytometry analysis: FITC-conjugated anti-CD19 (6D5) (BioLegend, San Diego, CA, USA, cat# 115505), APC-conjugated anti-CD11b (M1/70 ...
-
bioRxiv - Immunology 2023Quote: Single cell suspensions were stained for antibodies raised against the following antigens: CD45 FITC (30-F11, BioLegend), CD11b PE-Dazzle594 (M1/70 ...
-
bioRxiv - Immunology 2023Quote: ... Antigens were specifically stained using the following antibody clones for flow cytometry where indicated: CCR7 (CD197, Biolegend); CD45RA (H1100 ...
-
bioRxiv - Immunology 2021Quote: Recombinant human ARG1 was obtained from Biolegend (San Diego, CA, USA), recombinant murine Arg1 was obtained from Cloud-Clone Corp. ...
-
bioRxiv - Cell Biology 2021Quote: ... the cells were treated with recombinant TGF-β1 (580702, BioLegend®), as specified in figure legends ...
-
bioRxiv - Bioengineering 2020Quote: ... or none of the cytokines: recombinant murine TGFβ-1 (#763104, BioLegend), recombinant murine MMP-3 (#552704 ...
-
bioRxiv - Genomics 2022Quote: ... and 20 ng/mL of recombinant IL-6 (BioLegend, Cat# 575702) and 1 μg/mL of soluble anti-CD28 for 6 days at 37°C ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human transforming growth factor beta-1 (TGF-β1; Biolegend) were used at final concentrations of 10 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... and 1 U/mL of recombinant human IL-2 (BioLegend, #589102) in 200 μL of complete culture medium (see above for media components) ...
-
bioRxiv - Immunology 2023Quote: ... were coated with 1.54 μg/mL human recombinant VCAM-1 (Biolegend) and/or 1.14 μg/mL human recombinant ICAM-1 (R&D system ...
-
bioRxiv - Bioengineering 2023Quote: ... and 500 IU/ml of recombinant human IL-2 (Biolegend, 589104). Stimulated T cells were co-transduced via spinoculation at 931xg ...
-
bioRxiv - Cell Biology 2023Quote: ... HeLa cells were treated with TNF-α recombinant human protein (Biolegend) at a concentration of 75 ng/ml for 24 h in combination with cycloheximide (CHX ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 1000 U/ml of human recombinant IFN-γ (BioLegend), 20 ng/ml of EGF (Sigma ...
-
bioRxiv - Immunology 2024Quote: ... and 10 ng/ml of recombinant IL-13 (Cat# 575902, BioLegend). After 14-18 h ...
-
bioRxiv - Synthetic Biology 2021Quote: ... Anti-bodies used in this study included a monoclonal α-his-antibody (BioLegend, 652502) and polyclonal α-CsgA-antibody and α-TasA-antibody.
-
bioRxiv - Bioengineering 2022Quote: ... Confirmation of successful bead conjugation was determined by staining with anti-His Tag (Biolegend) and flow cytometry analysis ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... The Western blot membranes were stained with HRP anti-His tag antibody (Biolegend, #652504) diluted 1:2,000 in 0.5% (w/v ...
-
bioRxiv - Cell Biology 2021Quote: ... and an anti-FLAG AF549 conjugate (for cells expressing FLAG-tagged M; 1:1000, Biolegend, 637314) for 20 minutes at room temperature ...
-
bioRxiv - Immunology 2020Quote: ... Then these PBMCs was incubated with mixed antibodies cocktail at 4 °C for 30 min (the antibodies cocktail including FITC-anti-human CD19 antibody (Biolegend, clone: SJ25C1), BV421-anti-human IgD antibody (Biolegend ...
-
bioRxiv - Immunology 2020Quote: ... Harvested lymphocytes were washed three times with FACS buffer (5% FBS in PBS) and stained for surface markers using: CD19-PE (363003, Biolegend, RRID: AB_2564125), IgD-FITC (348206 ...
-
bioRxiv - Immunology 2020Quote: ... CD19+CD138+ plasma cells were isolated from PBMCs by positive selection using biotin conjugated CD138 antibody (352322, Biolegend, San Diego, CA, USA) and Easysep release human biotin positive selection cocktail (17653 ...
-
bioRxiv - Cancer Biology 2023Quote: ... The percentage of viable leukemic cells was determined by staining with Brilliant Violet 421 anti-human CD19 (Biolegend, San Diego, CA, USA), FITC Annexin V (Biolegend) ...
-
bioRxiv - Immunology 2024Quote: ... CD19-expressing K562 (CAR Activation) or CD64- and CD80-expressing K562 previously loaded with anti-CD3 antibody (OKT3, Biolegend, San Diego, CA) at 1 μg/ml for 1 hour 39 (TCR/CD28 Activation ...
-
bioRxiv - Immunology 2023Quote: ... Cells were washed and incubated in FACS buffer (1xPBS, 2%FCS) with the following anti-human antibodies: CD19-BV785 (BioLegend, 1:10), CD3-APC-eFluor 780 (Invitrogen ...
-
bioRxiv - Immunology 2021Quote: ... Monoclonal antibodies against the following antigens were used: CD3 (17A2, Biolegend, CD8a (53-6.7, Biolegend or BD Pharmingen), CD25 (PC61 ...
-
bioRxiv - Immunology 2020Quote: ... Cell surface antigens were stained with combinations of the following antibodies: CD93-FITC (AA4.1, Biolegend, San Diego CA), CD23-PE (B3B4 ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... a final concentration of 5ng/ml of recombinant human TGFβ1 (BioLegend, #580702) was added to the culture media and treated for 24~48 hours ...
-
bioRxiv - Immunology 2022Quote: ... 100ng/ml of recombinant human (rh) IL-8 (Biolegend, San Diego, CA) were added to the apical side of the enteroid monolayers (76) ...
-
bioRxiv - Biochemistry 2022Quote: ... or 0.5ng/mL of Wnt3a recombinant protein (BioLegend, San Diego, CA, #772301). Luciferase activity was measured by bioluminescence (Promega Dual-Glo Luciferase Assay System ...
-
bioRxiv - Immunology 2019Quote: ... 10% FBS and 20 ng/ml of murine recombinant M-CSF (Biolegend) at 37°C in a humidified incubator for 7–8 days ...
-
bioRxiv - Microbiology 2022Quote: ... in the presence of 50 ng/mL recombinant human M-CSF (Biolegend) for 7 days ...
-
bioRxiv - Microbiology 2022Quote: ... plated in complete RPMI with 50 ng/mL recombinant M-CSF (Biolegend) and cultured for 6 days with medium change every 3 days.
-
bioRxiv - Cancer Biology 2020Quote: ... in DMEM/F12 supplemented with human recombinant EGF (20 ng/mL, BioLegend), bFGF (20 ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... CAR-NK cells were loaded with human recombinant PD-L1- Fc (Biolegend) or ErBb2-Fc fusion proteins (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... and 200 ng/mL recombinant human B cell-activating factor (BAFF, BioLegend).
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL human recombinant IL-3 (BioLegend, San Diego, CA, USA) and antibiotics ...
-
bioRxiv - Microbiology 2023Quote: ... plated in complete RPMI with 50 ng/mL recombinant M-CSF (Biolegend) and cultured for 6 days with medium change every 3 days.
-
bioRxiv - Microbiology 2023Quote: ... in the presence of 50 ng/mL recombinant human M-CSF (Biolegend) for 7 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant human NRG1 was acquired from BioLegend (San Diego, CA, Cat. 551904). High-throughput drug screening assays were used with compounds sourced as indicated in Suppl ...
-
bioRxiv - Cancer Biology 2024Quote: ... in the presence of 10 ng/mL recombinant MIF (Biolegend, cat. 599404) or MDK (Biolegend ...
-
bioRxiv - Bioengineering 2021Quote: ... T cells were similarly isolated and stained with Ghost Dye and lineage/differentiation markers (without CD19) and with TIM-3 BV711 (Biolegend clone F38-2E2), LAG-3 BV421 (Biolegend clone 11C3C65) ...
-
bioRxiv - Genomics 2022Quote: ... Bone marrow mononuclear cells were stained for 30 minutes on ice with the following antibodies: anti-CD19(APC/Cy7) (clone HIB19; Biolegend; Cat. num. 302217) in a 1:20 dilution ...